We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NPB:NYSENorthpointe Bancshares, Inc. Analysis

Data as of 2026-07-17 - not real-time

$19.16

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Northpointe Bancshares is trading at $19.16, comfortably above its 20‑day SMA (≈$18.61) and 50‑day SMA (≈$17.93), signaling a bullish trend despite a modest bearish tilt in the MACD histogram. The RSI sits at 61, indicating healthy momentum without being overbought, while volume has been trending down, suggesting a potential short‑term softening as the stock approaches its resistance near $19.71. Valuation metrics are compelling: a trailing P/E of about 8x is well below the industry average of ~18x, and the price‑to‑book of 1.12 hovers just above book value, pointing to an undervalued position with an upside potential of roughly 12% versus consensus target prices around $22.
Fundamentally, NPB posted 27.9% revenue growth and maintains a solid operating margin of 46%, translating to a 35% profit margin and a respectable ROE of 15%. The dividend of $0.025 per share yields just over 0.5% with a payout ratio under 5%, indicating strong sustainability. Cash on hand (~$488 M) comfortably covers current obligations, though total debt exceeds $1.7 B, warranting monitoring. Recent material news is limited to a routine earnings release announcement and a dividend declaration, providing no immediate catalyst but underscoring stable shareholder communication.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price nearing resistance at $19.71
  • Decreasing volume trend
  • Bearish MACD histogram signal

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant revenue growth (≈28%)
  • Undervalued valuation relative to peers
  • Low beta (≈0.78) indicating defensive profile

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Strong operating margins and ROE
  • Potential sector recovery for regional banks

Key Metrics & Analysis

Financial Health

Revenue Growth27.90%
Profit Margin35.11%
P/E Ratio8.2
ROE15.01%
ROA1.33%
P/B Ratio1.1
Op. Cash Flow$27.6M
Industry P/E18.0

Technical Analysis

TrendBullish
RSI61.2
Support$17.63
Resistance$19.71
MA 20$18.61
MA 50$17.93
MA 200$17.52
MACDBearish
VolumeDecreasing
Fear & Greed Index88.73

Valuation

Target Price$21.42
Upside/Downside11.78%
GradeUndervalued
TypeBlend
Dividend Yield0.52%

Risk Assessment

Beta0.78
Volatility27.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.